Main Menu

Acute Leukaemia Team

This team aims to develop new therapeutic strategies for acute myeloid leukaemia (AML), a disease with a poor outcome for many patients. The team’s research focusses on improving understanding of the disease through studies on leukaemia stem cells and their interactions with normal haematopoietic stem cells.

Group leader

Dr David Taussig

Dr David Taussig

Associate Honorary Faculty

Dr David Taussig is a Consultant Haematologist at The Royal Marsden with an interest in acute leukaemia, and a Team Leader at the ICR.

ORCID 0000-0002-9621-0146

Group members

Dr Farideh Miraki-Moud

Higher Scientific Officer +44 20 8915 6664